Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine–Hydrazide Hydrazone Derivative
Molecules · 2024
DOI: 10.3390/molecules29102292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Joanna Wasiak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Medical University of Lodz, 6/8 Mazowiecka Str., 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: Tamoxifen, Breast Neoplasms, Aziridines, Apoptosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre, Medical University of Lodz.
Abstract (Originalsprache)
Breast cancer is associated with high mortality and morbidity rates. As about 20–30% of patients exhibiting ER-positive phenotype are resistant to hormonal treatment with the standard drug tamoxifen, finding new therapies is a necessity. Postbiotics, metabolites, and macromolecules isolated from probiotic bacteria cultures have been proven to have sufficient bioactivity to exert prohealth and anticancer effects, making them viable adjunctive agents for the treatment of various neoplasms, including breast cancer. In the current study, postbiotics derived from L. plantarum and L. rhamnosus cultures were assessed on an in vitro breast cancer model as potential adjunctive agents to therapy utilizing tamoxifen and a candidate aziridine–hydrazide hydrazone derivative drug. Cell viability and cell death processes, including apoptosis, were analyzed for neoplastic MCF-7 cells treated with postbiotics and synthetic compounds. Cell cycle progression and proliferation were analyzed by PI-based flow cytometry and Ki-67 immunostaining. Postbiotics decreased viability and triggered apoptosis in MCF-7, modestly affecting the cell cycle and showing a lack of negative impact on normal cell viability. Moreover, they enhanced the cytotoxic effect of tamoxifen and the new candidate drug toward MCF-7, accelerating apoptosis and the inhibition of proliferation. This illustrates postbiotics’ potential as natural adjunctive agents supporting anticancer therapy based on synthetic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Medical University of Lodz, 6/8 Mazowiecka Str., 92-215 Lodz, Poland.
- Department of Organic and Applied Chemistry, Faculty of Chemistry, University of Lodz, Tamka 12 Str., 91-403 Lodz, Poland.
- Department of Molecular Microbiology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16 Str., 90-237 Lodz, Poland.
ORCID-Profile: Agnieszka Pudlarz, Adam M Pieczonka, Katarzyna Dzitko, Janusz Szemraj, Monika Witusik-Perkowska
Förderung
- National Science Center
- National Science Centre
- Medical University of Lodz
Zitieren
APA
Wasiak, J., Głowacka, P., Pudlarz, A., Pieczonka, A. M., Dzitko, K., Szemraj, J., & Witusik-Perkowska, M. (2024). Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine–Hydrazide Hydrazone Derivative. Molecules. https://doi.org/10.3390/molecules29102292
Vancouver
Wasiak J, Głowacka P, Pudlarz A, Pieczonka AM, Dzitko K, Szemraj J, et al. Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine–Hydrazide Hydrazone Derivative. Molecules. 2024. doi:10.3390/molecules29102292
BibTeX
@article{Wasiak2024,
author = {Wasiak, Joanna and Głowacka, Pola and Pudlarz, Agnieszka and Pieczonka, Adam M and Dzitko, Katarzyna and Szemraj, Janusz and Witusik-Perkowska, Monika},
title = {Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine–Hydrazide Hydrazone Derivative},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29102292}
}
EUVIMED